angela sormani
Online education platform WizIQ has raised $4 million in Series B investment. The funding is led by Kaizen, an Indian education-focused private equity fund along with German-based global media business Bertelsmann.
Enterprise mobile application management business Apperian has received a strategic investment from Intel Capital, Intel's global investment and M&A organization. The additional capital will build on previous investments Bessemer Venture Partners, Kleiner Perkins Caufield & Byers and North Bridge Venture Partners and brings Apperian's total funding to date to $28 million.
Unilever Ventures and FF&P Private Equity, the private equity arm of Fleming Family & Partners, have realised their investment in BAC. The business has been sold to Life Technologies Corporation. BAC is a developer of affinity ligands and affinity purification products.
Frontier Capital has backed JobApp. The company is a software-as-a-service (SaaS) provider for recruiting and talent management systems of hourly and decentralized workers.
Business data provider Simply Measured has secured an $8 million venture round. The funding was led by Bessemer Venture Partners with MHS Capital and existing angels participating.
Manhattan Labs, a regional clinical laboratory serving the New York tri-state area has completed a $3.7 million investment round. The funding was led by existing investor Trevi Health Capital, a specialized healthcare investment firm.
Semetric, a global data analytics business, has secured 3 million pounds ($4.7 million) from Imperial Innovations Group and existing investor Pentech Ventures. It follows previous investments totalling 1.7 million pounds.
Optimal has secured $7 million in funding. New investors include DoubleRock, The Social Internet Fund, Siemer Ventures, Signal Ventures, John Pappajohn, Warren Adelman (former CEO of GoDaddy), Social Starts, James Altucher and Silicon Valley Bank. Paul Suh has joined the company as chief financial officer effective immediately.
Syapse has raised a Series A round of venture capital funding led by The Social+Capital Partnership. As part of this investment, Social Capital founder Chamath Palihapitiya has joined Syapse’s board of directors.
Lophius Biosciences, a developer of T-cell-based diagnostic test systems, has closed a further financing round. VRD GmbH, WIC GmbH and existing investors such as S-Refit, HighTech Gründerfonds, Bayern Kapital and two business angels have backed the business. Prof. Dr. Ralf Wagner, former CEO of GeneArt AG, has been appointed as managing director to drive the further development of the company with the current managing director Dr. Michael Lutz.